Macular Degeneration Stem Cell Clinical Trials

The supplements studied included vitamins c e beta carotene zinc and copper.

Macular degeneration stem cell clinical trials. A pioneering clinical trial of a new treatment derived from embryonic stem cells for people with wet age related macular degeneration amd has been initiated at moorfields eye hospital in london following a successful operation on a 60 year old woman. Found 71 clinical trials a phase 2 randomized double masked placebo controlled clinical study to evaluate the safety efficacy and pharmacokinetics of subcutaneous injections of elamipretide in subjects with age related macular degeneration with geographic atrophy reclaim 2. The clinical trial was designed to determine if people at risk for the development of the advanced stages of age related macular degeneration amd could lower their risk for progression and associated vision loss by ingesting high dose micronutrient supplements. As of early 2019 there were 233 clinical trials for macular degeneration registered with the national institutes of health.

Researchers in california expect to launch a phase 2 clinical trial of stem cell therapy for age related macular degeneration this year while a team from the national institutes of health is not.